India gabapentin market is expected
to grow at a steady rate during the forecast period. Gabapentin is an anticonvulsant
medication and was initially developed as a novel anti-epileptic for treating
numerous types of seizures. The India gabapentin market is driven by the certain
advantages of this drug over other anti-epileptics such as a wide therapeutic index,
among others. Moreover, Gabapentin is widely used to treat epilepsy which is
forecasted to positively influence the market growth. Ongoing research and
developmental activities by key market players is further expected to boost the
growth of India gabapentin market through FY2026.
The India gabapentin market is
segmented based on source, form, strength, distribution channel, application, end user, company, and region. Based on application,
the market can be segmented into epilepsy, neuropathic pain, restless legs
syndrome, seizures, others. Among these, neuropathic pain segment is expected
to witness high growth in the market over the coming years on account of high
growth in the number of population having chronic progressive nerve diseases.
Also, the efficient use of this drug for the treatment of neuropathic pain is
expected to drive this segmental growth in the years to come.
The major players operating in the
India gabapentin market are Aurobindo Pharma Ltd., Glenmark Pharmaceuticals
Ltd., Sun Pharmaceuticals Industries Ltd., Alkem Laboratories Ltd., Intas
Pharmaceuticals Ltd., Hetero Drugs Ltd., Silverline Chemicals Ltd., Taj
Pharmaceuticals Ltd., Divis Laboratories Ltd., Unnati Pharmaceuticals Pvt. Ltd.,
and others. Major companies are developing advanced technologies and launching new products
in order to stay competitive in the market. Other competitive Go-to- Market strategies
include mergers & acquisitions, research collaborations and new product
developments to expand their geographic reach and to increase their customer
basis.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
gabapentin market from FY2016 to FY2019.
- To estimate and forecast the market size of India
gabapentin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India gabapentin market
based on source, form, strength, distribution channel, application, end
user, company, and regional distribution.
- To identify dominant region or segment in the India
gabapentin market.
- To identify drivers and challenges for India gabapentin
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
gabapentin market.
- To identify and analyze the profile of leading
players operating in India gabapentin market.
- To identify key sustainable strategies adopted
by market players in India gabapentin market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India gabapentin market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Gabapentin manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to gabapentin
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India gabapentin market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Gabapentin Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Gabapentin Market, By Form:
- India Gabapentin Market, By Strength:
- 100 mg
- 200 mg
- 300 mg
- 400 mg
- Others
- India Gabapentin Market, By Distribution Channel:
- India Gabapentin Market, By Application:
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome (RLS)
- Seizures
- Others
- India Gabapentin Market, By End User:
- India Gabapentin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India gabapentin market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India gabapentin market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]